Collecting Blood and Urine Samples From Adults With Bladder Cancer
Collects blood and urine samples from adults with bladder cancer.
Plain-language title generated from the registry record
Registry title: Bladder Bank (a Prospective Banking Study)
Key facts
- Where
- Rochester, United StatesSee the site
Where in United States
- Mayo Clinic in RochesterRochester, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT06109857
- Record updated
- 14 October 2026
- Original description
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.Read full original descriptionShow less
Bladder Bank (a Prospective Banking Study)
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Inclusion: Age \> 18 years; Patient has undergone office-based evaluation for hematuria [computed tomography (CT), ultrasound, cystoscopy].
Exclusion: Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible); Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection; Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection; Patient has had any prior radiation therapy to the target lesion prior to current collection; Patient has had a biopsy to the target organ and/or lesion within 3 days before collection; Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection; Patient has had a urinary tract infection within 14 days prior to urine collection; Patient has recurrent muscle invasive bladder cancer; Patient has undergone cystectomy or cystoprostatectomy; Patient has chronic indwelling urinary catheter.